Fabros Achieves Record Profit Increase of 113% in Q1 2026
Fabros, a subsidiary of Indonesian Kimia Farma, reported a net profit of <strong>761.49 million rupiah</strong> in the first quarter of 2026, marking a significant increase of <strong>113%</strong> compared to the same period last year. This growth is attributed to increased sales and improved profit margins.